Activating and resistance mutations of EGFR in non-small-cell lung cancer: Role in clinical response to EGFR tyrosine kinase inhibitors

A. F. Gazdar

Research output: Contribution to journalReview articlepeer-review

617 Scopus citations

Fingerprint Dive into the research topics of 'Activating and resistance mutations of EGFR in non-small-cell lung cancer: Role in clinical response to EGFR tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences